Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
135.28
+2.48 (1.87%)
At close: May 31, 2024, 4:00 PM
135.62
+0.34 (0.25%)
After-hours: May 31, 2024, 7:58 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 133, with a low estimate of 115 and a high estimate of 163. The average target predicts a decrease of -1.69% from the current stock price of 135.28.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 18, 2024.
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +18.27% | Apr 18, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $163 | Buy | Initiates | $163 | +20.49% | Apr 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +18.27% | Apr 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +18.27% | Apr 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +18.27% | Mar 20, 2024 |
Financial Forecast
Revenue This Year
292.92B
from 232.26B
Increased by 26.12%
Revenue Next Year
353.78B
from 292.92B
Increased by 20.78%
EPS This Year
23.62
from 18.62
Increased by 26.86%
EPS Next Year
28.95
from 23.62
Increased by 22.56%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 317.8B | 418.1B | 481.7B | 558.0B | 659.2B |
| Avg | 292.9B | 353.8B | 409.4B | 442.5B | 475.8B |
| Low | 267.2B | 303.9B | 345.3B | 363.1B | 396.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.8% | 42.7% | 36.2% | 36.3% | 49.0% |
| Avg | 26.1% | 20.8% | 15.7% | 8.1% | 7.5% |
| Low | 15.1% | 3.7% | -2.4% | -11.3% | -10.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.25 | 34.32 | 41.72 | 46.05 | 51.17 |
| Avg | 23.62 | 28.95 | 34.26 | 36.41 | 38.90 |
| Low | 21.56 | 24.16 | 27.39 | 28.45 | 31.67 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 41.0% | 45.3% | 44.1% | 34.4% | 40.5% |
| Avg | 26.9% | 22.6% | 18.3% | 6.3% | 6.8% |
| Low | 15.8% | 2.3% | -5.4% | -16.9% | -13.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.